Novozymes A/S
CSE:NSIS B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Novozymes A/S (NSIS B) under the Base Case is DKK per share.
Compared with the current market price of 460 DKK, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Novozymes A/S Does
Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly.
- Headquarters
- Denmark DK
- Employees
- 6 184
- IPO date
- May 27, 1905
Earnings Waterfall
Novozymes A/S
What is the Intrinsic Value of one NSIS B stock?
The intrinsic value for Novozymes A/S (NSIS B) under the Base Case is DKK.
Is NSIS B stock undervalued or overvalued?
Compared with the current market price of 460 DKK, the stock appears .
